BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15547699)

  • 1. Expression of HLA class I antigen and proteasome subunits LMP-2 and LMP-10 in primary vs. metastatic breast carcinoma lesions.
    Gobbi G; Mirandola P; Micheloni C; Solenghi E; Sponzilli I; Artico M; Soda G; Zanelli G; Pelusi G; Fiorini T; Cocco L; Vitale M
    Int J Oncol; 2004 Dec; 25(6):1625-9. PubMed ID: 15547699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
    Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
    Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
    Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
    J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
    Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
    Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.
    Ryu KS; Lee YS; Kim BK; Park YG; Kim YW; Hur SY; Kim TE; Kim IK; Kim JW
    Exp Mol Med; 2001 Sep; 33(3):136-44. PubMed ID: 11642549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.
    Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M
    Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
    Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
    Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
    Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and beta2-microglobulin downregulation in breast cancer.
    Morabito A; Dozin B; Salvi S; Pasciucco G; Balbi G; Laurent S; Pastorino S; Carli F; Truini M; Bruzzi P; Del Mastro L; Pistillo MP
    Hum Immunol; 2009 Jul; 70(7):492-5. PubMed ID: 19410618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight protein (LMP)2/LMP7 abnormality underlies the downregulation of human leukocyte antigen class I antigen in a hepatocellular carcinoma cell line.
    Shen YQ; Zhang JQ; Xia M; Miao FQ; Shan XN; Xie W
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1155-61. PubMed ID: 17608862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility antigens and antigen-processing molecules in retinoblastoma.
    Krishnakumar S; Sundaram A; Abhyankar D; Krishnamurthy V; Shanmugam MP; Gopal L; Sharma T; Biswas J
    Cancer; 2004 Mar; 100(5):1059-69. PubMed ID: 14983503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma.
    Weinman EC; Roche PC; Kasperbauer JL; Cha SS; Sargent DJ; Cheville J; Murphy LM; Chen L; Wettstein PJ; Gostout B; Ferrone S; Strome SE
    Cancer; 2003 May; 97(9):2203-11. PubMed ID: 12712472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis.
    Kamarashev J; Ferrone S; Seifert B; Böni R; Nestle FO; Burg G; Dummer R
    Int J Cancer; 2001 Jan; 95(1):23-8. PubMed ID: 11241306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.
    Ritz U; Momburg F; Pilch H; Huber C; Maeurer MJ; Seliger B
    Int J Oncol; 2001 Dec; 19(6):1211-20. PubMed ID: 11713591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells.
    Pantel K; Schlimok G; Kutter D; Schaller G; Genz T; Wiebecke B; Backmann R; Funke I; Riethmüller G
    Cancer Res; 1991 Sep; 51(17):4712-5. PubMed ID: 1873815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
    Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
    J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+ T cells.
    Housseau F; Bright RK; Simonis T; Nishimura MI; Topalian SL
    J Immunol; 1999 Dec; 163(11):6330-7. PubMed ID: 10570328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.
    Raffaghello L; Nozza P; Morandi F; Camoriano M; Wang X; Garrè ML; Cama A; Basso G; Ferrone S; Gambini C; Pistoia V
    Cancer Res; 2007 Jun; 67(11):5471-8. PubMed ID: 17545629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility complex (MHC)-I and MHC-II expression in Hodgkin's disease in relation to the presence of Epstein-Barr Virus (EBV).
    Tzardi M; Kouvidou C; Papakonstantinou E; Datseris G; Darivianaki K; Karidi E; Eliopoulos G; Delidis G; Rontogianni D; Kanavaros P
    Anticancer Res; 1996; 16(2):827-31. PubMed ID: 8687136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.